ACTRN12618000618257
Terminated
未知
.Amyloid deposition and cognitive function in Obstructive Sleep Apnoea
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Obstructive Sleep Apnoea
- Sponsor
- Institute for Breathing and Sleep
- Enrollment
- 46
- Status
- Terminated
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged 50\-75 years; OSA diagnosis (AHI\>15 events/hr); are OSA treatment\-naïve; sufficient English to undertake cognitive testing; able to provide informed consent.
- •Healthy controls will be age\- and gender\-matched to the OSA group. The will be required to have sufficient English to undertake cognitive testing; able to provide informed consent; must have no sleep disorder (AHI \<5 events/hr).
Exclusion Criteria
- •Active medical or psychiatric condition that may interfere with study procedures; or a previous diagnosis of dementia; pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Post-stroke cognitive trajectory according to amyloid depositioDiseases of the nervous systemKCT0005086The Catholic University of Korea, Eunpyeong St. Mary's Hospital196
Not yet recruiting
Phase 4
Characterization of cerebral amyloid deposition with 18F-Flutemetamol PET and of glucose metabolism with 18F-FDG PET in individuals enrolled in the ALFA project2024-519961-23-00Barcelonabeta Brain Research Center400
Not yet recruiting
Phase 2
Amyloid pathology in cognitively normal elderly subjects (PreclinAD)2024-518559-41-01Amsterdam UMC Stichting204
Recruiting
Not Applicable
Amyloid pathology in cognitively normal elderly subjectsAlzheimer's diseasedementia10042258NL-OMON55380Vrije Universiteit Medisch Centrum200
Completed
Not Applicable
Measurement of amyloid deposit in the brain of idiopathic normal-pressure hydrocephalusJPRN-UMIN000003764Cyclotron and Radioisotope Center (CYRIC), Tohoku University90